Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-04-11 @ 11:18 AM
Study NCT ID:
NCT00121095
Status:
UNKNOWN
Last Update Posted:
2007-12-21
First Post:
2005-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Sponsor:
Cytogen Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
424Sm32
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Michael Manyak, MD
Old Organization:
Cytogen Corporation